SecBot SecBot
DEFA14A ·Filed Aug 14, 2026

PHIO

Phio Pharmaceuticals Corp.
NEUTRAL
Impact 3/10
Horizondays Processed3mo ago SEC0001683168-26-006474
Proxy solicitation materials
Actionable Insight • Neutral

This is a routine proxy notice with no material financial or operational news. The proposed 1,500,000 share increase to the equity plan is modest for a $13M market cap company and is standard practice. Monitor the actual vote outcome and any subsequent 8-K for dilution details, but no immediate trading action is warranted.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$1.06
T+0 close · Aug 14, 2026 · via day close
Latest settled
−23.23%
T+60 · $0.8138
Vs SPY
−20.28%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 17 $1.06entry
  2. T+1 · 3mo ago −0.94%α −0.27% · $1.05
  3. T+5 · 3mo ago +10.38%α +11.57% · $1.17
  4. T+20 · 2mo ago −3.77%α −1.80% · $1.02
  5. T+60 · 7d ago −23.23%α −20.28% · $0.8138
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Phio Pharmaceuticals Corp. filed a DEFA14A (additional definitive proxy soliciting materials) for its 2026 Annual Meeting of Stockholders to be held on September 28, 2026. The filing is a routine notice providing instructions for accessing proxy materials and voting online, with the Board recommending votes FOR all six director nominees, ratification of Grant Thornton as auditor, and approval of a 1,500,000 share increase to the 2020 Long Term Incentive Plan. No financial results, activist activity, or material corporate events are disclosed.

Key Financial Metrics

Vote
director election
Meeting
2026-09-28

Key Facts

  • Annual Meeting scheduled for September 28, 2026, held virtually.
  • Record date for voting is August 4, 2026.
  • Board recommends FOR election of six director nominees: Robert J. Bitterman, Patricia A. Bradford, David H. Deming, Jonathan E. Freeman, Curtis A. Lockshin, and R. Todd Plott.
  • Board recommends FOR ratification of Grant Thornton, LLP as independent auditor for FY 2026.
  • Board recommends FOR amendment to 2020 Long Term Incentive Plan to increase shares available by 1,500,000.
  • Filing is a routine DEFA14A notice; no financial data or material events reported.

Financial Impact

No financial figures reported in this filing.

Risk Factors

  • Potential dilution from 1,500,000 share increase to the equity plan, though amount is small relative to market cap.
  • No financial or operational updates in this filing; risk of negative news at the meeting or in future filings.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001683168-26-006474
Document: 0001683168-26-006474-index-headers.html0001683168-26-006474
Document: 0001683168-26-006474-index.html0001683168-26-006474
Document: 0001683168-26-006474.txt0001683168-26-006474

Track record

7 reports on PHIO

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 5, 202611d ago 8-K Bearish 5/10 Entry $0.8013 to $0.7710 Now $0.7520 +6.15% ▲ +3.78% +6.38% vs SPY
  2. Oct 13, 20264w ago 8-K Neutral 3/10 Entry $0.9345 to $0.8921 Now $0.7520 −19.53% ▼ −4.54% −3.39% vs SPY
  3. Sep 14, 20269w ago 8-K Bullish 5/10 Entry $1.03 to $1.01 Now $0.7520 −26.99% ▼ −1.94% −2.05% vs SPY
  4. Aug 14, 202613w ago DEFA14A Neutral 3/10 Viewing Entry $1.06 to $1.17 Now $0.7520 −29.06% ▲ +10.38% +11.57% vs SPY
  5. Apr 8, 202631w ago 8-K Neutral 5/10 Entry $1.25 to $1.27 Now $0.7520 −39.84% ▲ +1.60% −1.59% vs SPY
  6. Apr 8, 202631w ago 424B5 Neutral 5/10 Entry $1.25 to $1.27 Now $0.7520 −39.84% ▲ +1.60% −1.59% vs SPY
  7. Mar 5, 202636w ago 8-K Mixed 6/10 Entry $1.16 to $1.17 Now $0.7520 −35.17% ▲ +0.86% +2.39% vs SPY
Showing 7 of 7

US Market Status

Market Closed · Opens in 6h 38m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 14, 2026